| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $9.8M | — | +145.0% |
| SG&A Expense | $6.4M | — | +56.6% |
| Operating Income | -$16.3M | — | -100.3% |
| Interest Expense | $1.6M | — | +411.1% |
| Net Income | -$8.9M | — | -220.1% |
| EPS (Basic) | -$0.14 | — | -193.3% |
| EPS (Diluted) | -$0.14 | — | -207.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $194.8M | +62.7% | +111.4% |
| Current Assets | $197.8M | +62.9% | +112.3% |
| Total Assets | $201.9M | +61.3% | +110.5% |
| Current Liabilities | $7.1M | -21.6% | -64.9% |
| Total Liabilities | $63.9M | -12.8% | +200.9% |
| Stockholders' Equity | $138.0M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$18.0M | — | -109.3% |
| Capital Expenditures | $675K | — | — |
| Investing Cash Flow | -$675K | — | — |
| Financing Cash Flow | $93.8M | — | +5116.8% |
| Free Cash Flow | -$18.7M | — | -117.1% |
| +84.8% |